BioVersys AG header image

BioVersys AG

BIOV

Equity

ISIN CH0210362643 / Valor 21036264

SIX Swiss Exchange (2026-04-29)
CHF 28.95+1.36%

BioVersys AG
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

BioVersys AG is a privately held Swiss pharmaceutical company based in Basel, specializing in the research and development of small molecule therapies to combat bacterial infections. The company focuses on designing novel antibiotics that employ unique mechanisms of action and target previously unexplored bacterial pathways, addressing the urgent need for effective treatments against antibiotic-resistant strains. By leveraging proprietary technologies and innovative approaches, BioVersys aims to advance its pipeline of antimicrobial agents, contributing to the global effort to fight bacterial resistance and improve patient outcomes.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-11.0%1Y
%3Y
%5Y

Performance

58.6%1Y
56.4%3Y
56.4%5Y

Volatility

Market cap

221 M

Market cap (USD)

Daily traded volume (Shares)

821

Daily traded volume (Shares)

1 day high/low

/

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Progyny Inc
Progyny Inc Progyny Inc Valor: 50342281
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.16%USD 18.38
Baxter International Inc
Baxter International Inc Baxter International Inc Valor: 911702
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.97%USD 17.94
Ste Virbac SA
Ste Virbac SA Ste Virbac SA Valor: 524407
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.88%EUR 366.00
Amphastar Pharmaceuticals Inc
Amphastar Pharmaceuticals Inc Amphastar Pharmaceuticals Inc Valor: 24511852
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.79%USD 21.82
Trupanion Inc
Trupanion Inc Trupanion Inc Valor: 24738737
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-8.40%USD 24.96
Interparfums
Interparfums Interparfums Valor: 86977
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.66%EUR 24.00
Guardant Health Inc
Guardant Health Inc Guardant Health Inc Valor: 43633454
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-6.11%USD 83.09
SOLVENTUM CORP
SOLVENTUM CORP SOLVENTUM CORP Valor: 133635906
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.25%USD 67.51
Agenus Inc
Agenus Inc Agenus Inc Valor: 134326284
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-4.89%USD 3.89
Edgewise Therapeutics Inc
Edgewise Therapeutics Inc Edgewise Therapeutics Inc Valor: 110444153
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.14%USD 30.99